Close Menu

NEW YORK (GenomeWeb) – Guardant Health said after the close of the market Monday that it has commenced a public offering of up to 4.5 million shares of its common stock. In addition, the company expects to grant underwriters a 30-day option to purchase an additional 675,000 shares.

JP Morgan Securities and BofA Merrill Lynch are serving as joint lead book-running managers. A registration statement related to the securities has been filed with the SEC but is not yet effective.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.